Amgen Inc.
Growth differentiation factor 15 (GDF-15) constructs

Last updated:

Abstract:

Constructs comprising GDF15, and mutants thereof are provided. In various embodiments the constructs comprising GDF15, and mutants thereof, can be of use in the treatment or ameliorating a metabolic disorder. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.

Status:
Grant
Type:

Utility

Filling date:

29 Nov 2017

Issue date:

19 Jan 2021